Next Article in Journal
STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications
Next Article in Special Issue
Matrix Metalloproteinases: The Gene Expression Signatures of Head and Neck Cancer Progression
Previous Article in Journal
HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins
Previous Article in Special Issue
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression
Article Menu

Export Article

Open AccessReview
Cancers 2014, 6(1), 366-375; doi:10.3390/cancers6010366

The Role of Matrix Metalloproteinases in Colorectal Cancer

Division of Gastroenterology and Hepatology, Veterans Affairs Maryland Health Care System, University of Maryland School of Medicine, Baltimore, MD 21201, USA
Author to whom correspondence should be addressed.
Received: 12 December 2013 / Revised: 24 January 2014 / Accepted: 26 January 2014 / Published: 10 February 2014
(This article belongs to the Special Issue Matrix Metalloproteinases in Cancer Progress)
View Full-Text   |   Download PDF [352 KB, uploaded 10 February 2014]


In the United States, colorectal cancer (CRC) is the third leading cause of cancer mortality, with limited treatment options for those with advanced disease. Matrix metalloproteinases (MMPs) are important for maintaining extracellular homeostasis but also play a prominent role in cancer cell invasion and dissemination. Expression levels of MMP-1, -2, -7, -9 and -13 correlate with worse outcomes; MMP-12 expression appears to be protective. Hence, MMPs are attractive therapeutic targets. Previous clinical trials using broad-spectrum MMP inhibitors were disappointing because of off-target toxicity and lack of efficacy. Now, the availability of safer, more selective inhibitors has renewed interest in therapeutic targeting of MMPs. View Full-Text
Keywords: matrix metalloproteinases (MMPs); colorectal cancer; tissue inhibitors of metalloproteinases (TIMPs); matrix metalloproteinase inhibitors (MMPIs) matrix metalloproteinases (MMPs); colorectal cancer; tissue inhibitors of metalloproteinases (TIMPs); matrix metalloproteinase inhibitors (MMPIs)
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Said, A.H.; Raufman, J.-P.; Xie, G. The Role of Matrix Metalloproteinases in Colorectal Cancer. Cancers 2014, 6, 366-375.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top